Trial Profile

Comparison of Cephalexin Versus Clindamycin in the Empiric, Outpatient Treatment of Suspected Staphylococcal Cutaneous Infections in the Era of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 16 May 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cefalexin (Primary) ; Clindamycin
Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
Focus Therapeutic Use

18 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
18 Aug 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
05 Nov 2007 Status changed from initiated to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com